0001062993-22-018768.txt : 20220825
0001062993-22-018768.hdr.sgml : 20220825
20220825183613
ACCESSION NUMBER: 0001062993-22-018768
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220825
FILED AS OF DATE: 20220825
DATE AS OF CHANGE: 20220825
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: NAPIERSKI RYAN S
CENTRAL INDEX KEY: 0001652984
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12421
FILM NUMBER: 221199075
MAIL ADDRESS:
STREET 1: C/O NU SKIN ENTERPRISES INC
STREET 2: 75 WEST CENTER STREEET
CITY: PROVO
STATE: UT
ZIP: 84601
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NU SKIN ENTERPRISES, INC.
CENTRAL INDEX KEY: 0001021561
STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122]
IRS NUMBER: 870565309
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 75 WEST CENTER ST
STREET 2: ATTN: GREGORY BELLISTON
CITY: PROVO
STATE: UT
ZIP: 84601
BUSINESS PHONE: 801-345-1000
MAIL ADDRESS:
STREET 1: 75 WEST CENTER ST
STREET 2: ATTN: GREGORY BELLISTON
CITY: PROVO
STATE: UT
ZIP: 84601
FORMER COMPANY:
FORMER CONFORMED NAME: NU SKIN ENTERPRISES INC
DATE OF NAME CHANGE: 19980909
FORMER COMPANY:
FORMER CONFORMED NAME: NU SKIN ASIA PACIFIC INC
DATE OF NAME CHANGE: 19960919
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0306
4
2022-08-25
0001021561
NU SKIN ENTERPRISES, INC.
NUS
0001652984
NAPIERSKI RYAN S
C/O NU SKIN ENTERPRISES, INC.
75 WEST CENTER STREET
PROVO
UT
84601
1
1
0
0
President and CEO
Class A Common Stock
2022-08-25
4
M
0
13000
37.58
A
135683
D
Class A Common Stock
2022-08-25
4
M
0
12000
30.63
A
147683
D
Class A Common Stock
2022-08-25
4
S
0
12251
42.76
D
135432
D
Class A Common Stock
2022-08-25
4
S
0
12749
43.22
D
122683
D
Employee Stock Option (Right to Buy)
37.58
2022-08-25
4
M
0
13000
0
D
2022-12-18
Class A Common Stock
13000
12000
D
Employee Stock Option (Right to Buy)
30.63
2022-08-25
4
M
0
12000
0
D
2023-03-02
Class A Common Stock
12000
32000
D
Sale pursuant to a 10b5-1 plan adopted by the Reporting Person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.02 to $43.01, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.02 to $43.41, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
Currently exercisable in full.
/s/ Gregory Belliston as Attorney-in-Fact for Ryan S. Napierski
2022-08-25